In vitro efficacy of newly designed vancomycin-based microparticles

Area of Science:

• Ophthalmology
• Infectious Diseases
• Materials Science

Background:

• Bacterial infections, particularly those caused by Staphylococcus epidermidis, pose a significant risk in ophthalmic procedures.
• Perioperative antibiotic prophylaxis and endophthalmitis prevention are critical for patient outcomes.
• Novel drug delivery systems are being explored to enhance antibiotic efficacy and duration.

Purpose of the Study:

• To compare the in vitro bactericidal and anti-adhesion properties of vancomycin-based microparticles against lyophilized vancomycin.
• To assess the potential of vancomycin microparticles for perioperative antibiotic prophylaxis and endophthalmitis prevention.

Main Methods:

• In vitro assessment of vancomycin microparticles and lyophilized vancomycin against Staphylococcus epidermidis (strain N890074).
• Evaluation of bactericidal and anti-adhesion effects using bacterial counts and scanning electron microscopy.
• Experiments conducted in bacterial suspension and with intraocular lenses.

Main Results:

• Both vancomycin microparticles and lyophilized vancomycin exhibited significant bactericidal and anti-adhesion effects.
• The onset of action for microparticles was slightly delayed compared to lyophilized vancomycin.
• No significant difference in long-term bactericidal or anti-adhesion effects was observed between the two formulations.

Conclusions:

• Vancomycin microparticles retain their antibacterial and anti-adhesion efficacy after encapsulation.
• The newly designed microparticles show promise as an effective drug delivery system for ophthalmic applications.
• Vancomycin microparticles represent a viable option for enhancing antibiotic prophylaxis and preventing endophthalmitis.